Non-Fiction Books:

Focal Neuropathies

Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

Format:

Hardback
$625.99
Releases

Pre-order to reserve stock from our first shipment. Your credit card will not be charged until your order is ready to ship.

Available for pre-order now

Buy Now, Pay Later with:

4 payments of $156.50 with Afterpay Learn more

Pre-order Price Guarantee

If you pre-order an item and the price drops before the release date, you'll pay the lowest price. This happens automatically when you pre-order and pay by credit card.

If paying by PayPal, Afterpay, Zip or internet banking, and the price drops after you have paid, you can ask for the difference to be refunded.

If Mighty Ape's price changes before release, you'll pay the lowest price.

Availability

This product will be released on

Delivering to:

It should arrive:

  • 7-14 June using International Courier

Description

Facial Neuropathies, Volume 202 summarizes research and treatment on focal neuropathies to update clinicians on nerve biology and new diagnostic techniques to guide investigation and treatment of mononeuropathies. The book explores research broadly applicable to all types of mononeuropathies as well as individual mononeuropathy syndromes. Chapters on individual mononeuropathies include anatomy, causes, controversial diagnoses, and current or potential future treatments.

Author Biography:

Colin Chalk graduated from McGill University (MD,CM 1984), trained in neurology at Mayo Clinic and Oxford University, and completed a fellowship in peripheral nerve diseases at Mayo Clinic. He returned to McGill in 1991. From 2004 to 2019 he was the Director of the Division of Neurology, Montréal General Hospital. He runs peripheral neuropathy and myasthenia gravis clinics at the Montréal General Hospital, and is in charge of the Montréal General’s EMG laboratory. He also has a major administrative and teaching role in the McGill Faculty of Medicine’s undergraduate medical curriculum. His scholarly work in neuromuscular disease includes several Cochrane reviews, participation in multicentre clinical trials, and papers on clinical aspects of neuromuscular disease.
Release date Australia
June 1st, 2024
Audience
  • Professional & Vocational
Contributor
  • Volume editor Colin Chalk
Pages
305
ISBN-13
9780323901086
Product ID
38264918

Customer previews

Nobody has previewed this product yet. You could be the first!

Write a Preview

Help & options

Filed under...